Apolipoprotein E mimetic peptide, CN-105, improves outcomes in ischemic stroke.
about
Huperzine A alleviates neuroinflammation, oxidative stress and improves cognitive function after repetitive traumatic brain injury.Assessment of R18, COG1410, and APP96-110 in Excitotoxicity and Traumatic Brain Injury.Apolipoprotein E as a novel therapeutic neuroprotection target after traumatic spinal cord injury.
P2860
Apolipoprotein E mimetic peptide, CN-105, improves outcomes in ischemic stroke.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Apolipoprotein E mimetic peptide, CN-105, improves outcomes in ischemic stroke.
@en
Apolipoprotein E mimetic peptide, CN-105, improves outcomes in ischemic stroke.
@nl
type
label
Apolipoprotein E mimetic peptide, CN-105, improves outcomes in ischemic stroke.
@en
Apolipoprotein E mimetic peptide, CN-105, improves outcomes in ischemic stroke.
@nl
prefLabel
Apolipoprotein E mimetic peptide, CN-105, improves outcomes in ischemic stroke.
@en
Apolipoprotein E mimetic peptide, CN-105, improves outcomes in ischemic stroke.
@nl
P2093
P2860
P356
P1476
Apolipoprotein E mimetic peptide, CN-105, improves outcomes in ischemic stroke
@en
P2093
Brad J Kolls
Daniel T Laskowitz
Erik J Soderblom
Haichen Wang
Hana N Dawson
M Arthur Moseley
Paul Durham Ferrell
Viviana Cantillana
P2860
P304
P356
10.1002/ACN3.399
P50
P577
2017-03-09T00:00:00Z